TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT06560307: Examination of Programming with the Enterra® Therapy System in a Double-Blinded, Randomized, Prospective Study in the Treatment of Nausea and Vomiting Symptoms Using Gastric Electrical Stimulation

Sponsor: Enterra Medical, Inc. · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 50 pts

Competing Trials Overlap

5 Active Trials

Excess Burn Exposure

$6,374,400

Rescue Site Savings

+$4,216,400

Unlock Full NCT06560307 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06560307 Rescue Dossier →